Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program

Back

EHRA Premium Access

Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program

Session: What is new in atrial fibrillation?

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Speaker: Professor G. Lip (Liverpool, GB)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

100 presentations

9 followers

9 more presentations in this session

Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring.

Speaker: Doctor P. Papakonstantinou (Dublin, IE)

Access

Slides

Video

Aetiology-dependent atrial remodelling - a translational approach to characterise disease specific atrial cardiomyopathies in arterial hypertension and diabetic mellitus

Speaker: Doctor A. Bukowska (Magdeburg, DE)

Baseline echocardiography-indicated impaired atrial function predicts reoccurrence and thromboembolic risks after catheter ablation of atrial fibrillation

Speaker: Doctor S. Chu (Beijing, CN)

PR interval prolongation as intermediate phenotype for atrial fibrillation: Association with echocardiographic parameters and biomarkers (the LIFE-Adult-Study)

Speaker: Doctor J. Kornej (Boston, US)

Access

Abstract

Trends in hospital admissions for atrial fibrillation in Australia: a relentless rise

Speaker: Ms C. Gallagher (Adelaide, AU)

Access

Abstract

Access the full session

What is new in atrial fibrillation?

Speakers: Professor G. Lip, Doctor P. Papakonstantinou, Doctor A. Bukowska, Doctor S. Chu, Doctor J. Kornej...

Access

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources